CRAYON
Every story · every side  ·  est. 1995
Business

Teva Outlines Aggressive R&D Strategy with $7 Billion in Innovative Medicine Revenue by 2030

Photo: Benzinga
▲ Sign in to vote stories up

Coverage 1 source · 1 report

Chronological.

  1. Benzinga FIRST 1h ago Teva Outlines Aggressive R&D Strategy with $7 Billion in Innovative Medicine Revenue by 2030

Discussion 0 comments